Garcia-Alamino J M, Perrotta C, Clopés A, Parera A, Pérez-de-la-Ossa N, Bonfill X
Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Methods Find Exp Clin Pharmacol. 2006 Oct;28(8):527-31.
It is thought that the controlled trial (CT) is the most adequate research method to assess a therapeutic intervention in terms of efficacy, and it also constitutes the basis for the development of systematic reviews on health interventions. To identify and obtain the majority of published CTs is not an easy task, mainly because of limitations concerning the currently available electronic sources. The aim of the present work was to identify, describe, and assess the quality of CTs published in the journal Methods and Findings in Experimental and Clinical Pharmacology (M&F). Additionally, to assess the retrievability of both methods, a search was performed in Medline (PubMed access) through the use of an optimal search strategy for CTs. A total of 189 original studies out of a total of 2796 reviewed articles met the CT criteria according to the Jadad scale score, we could hold that only 58% of the CTs were of good quality. The present work confirms, once again, the limitations of a CT search performed exclusively through Medline (sensitivity 64% and specificity 98%). In conclusion, we suggest that the journal M&F explicitly joins the International CONSORT Statement.
人们认为,对照试验(CT)是评估治疗干预疗效的最适当研究方法,它也是开展健康干预系统评价的基础。识别并获取大多数已发表的对照试验并非易事,主要是因为现有电子资源存在局限性。本研究的目的是识别、描述并评估发表在《实验与临床药理学方法与发现》(M&F)杂志上的对照试验的质量。此外,为评估两种方法的可检索性,通过使用针对对照试验的最佳检索策略在Medline(PubMed接入)中进行了检索。根据Jadad量表评分,在总共2796篇综述文章中,共有189项原始研究符合对照试验标准,我们可以认为只有58%的对照试验质量良好。本研究再次证实了仅通过Medline进行对照试验检索的局限性(灵敏度64%,特异度98%)。总之,我们建议M&F杂志明确加入国际CONSORT声明。